Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


08.04.2019

1 Actas Urol Esp
1 BMJ Case Rep
3 Can J Urol
1 Cancer Control
2 Cancer Cytopathol
1 Cancer Med
1 Ceylon Med J
1 Crit Rev Oncol Hematol
1 Curr Opin Urol
1 Curr Probl Cancer
1 Eur Urol Oncol
2 Front Oncol
1 Future Oncol
2 Histopathology
1 In Vivo
1 Indian J Cancer
1 Int J Cancer
2 Int J Oncol
2 Int Urol Nephrol
1 J BUON
1 J Cell Mol Med
2 J Cell Physiol
1 J Exp Clin Cancer Res
1 J Pathol
1 J Urol
1 Korean J Radiol
1 Mod Pathol
1 Mol Cancer Ther
1 Mol Immunol
1 Mol Ther
1 Oncologist
1 Scand J Urol
1 Toxicol Appl Pharmacol
1 World J Urol
1 Zhonghua Wai Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Actas Urol Esp

  1. SUBIRA-RIOS D, Herranz-Amo F, Moralejo-Garate M, Cano-Velasco J, et al
    Post-surgical complications in patients with bladder cancer treated with cystectomy: Differences between open and laparoscopic approach.
    Actas Urol Esp. 2019 Mar 29. pii: S0210-4806(19)30006.
    PubMed     Text format     Abstract available


    BMJ Case Rep

  2. GARG G, Sharma A, Sharma A, Sankhwar S, et al
    Metastatic adenocarcinoma of bladder presenting with skin and visceral metastasis.
    BMJ Case Rep. 2018;11.
    PubMed     Text format     Abstract available


    Can J Urol

  3. MORGANSTERN BA, Scaccia S, Wu W, Williamson AK, et al
    Synchronous, but separate, bladder and vaginal rhabdomyosarcoma: a novel genetic case report.
    Can J Urol. 2018;25:9357-9359.
    PubMed     Text format     Abstract available

  4. LEE AJ, Yabes JG, Hale N, Hrebinko RL, et al
    The comparative effectiveness of quadratus lumborum blocks and paravertebral blocks in radical cystectomy patients.
    Can J Urol. 2018;25:9255-9261.
    PubMed     Text format     Abstract available

  5. MCARDLE BJ, Vidal P, Psutka SP, Hollowell CMP, et al
    T4 urothelial carcinoma in undiagnosed closed bladder exstrophy in a post-menopausal female.
    Can J Urol. 2018;25:9214-9216.
    PubMed     Text format     Abstract available


    Cancer Control

  6. MINATO A, Noguchi H, Tomisaki I, Fukuda A, et al
    Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
    Cancer Control. 2018;25:1073274818800269.
    PubMed     Text format     Abstract available


    Cancer Cytopathol

  7. PIERCONTI F, Rossi ED, Straccia P, Fadda G, et al
    The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration.
    Cancer Cytopathol. 2018;126:200-206.
    PubMed     Text format     Abstract available

  8. WANG Y, Auger M, Kanber Y, Caglar D, et al
    Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the "atypical" category and an increase in its prediction of subsequent high-grade urothelial carcinoma.
    Cancer Cytopathol. 2018;126:207-214.
    PubMed     Text format     Abstract available


    Cancer Med

  9. HAGGSTROM C, Garmo H, de Luna X, Van Hemelrijck M, et al
    Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study.
    Cancer Med. 2019 Apr 1. doi: 10.1002/cam4.2126.
    PubMed     Text format     Abstract available


    Ceylon Med J

  10. JAYARAJAH U, Fernando MH, Herath KB, Kuruppu SN, et al
    Clinico-pathological characteristics and outcome of upper urinary tract urothelial carcinoma presenting to a tertiary care urology unit in Sri Lanka
    Ceylon Med J. 2018;63:129-132.
    PubMed     Text format     Abstract available


    Crit Rev Oncol Hematol

  11. MAIA MC, Hansen A, Alves C, Salah S, et al
    Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A review.
    Crit Rev Oncol Hematol. 2019;135:76-84.
    PubMed     Text format     Abstract available


    Curr Opin Urol

  12. DASON S, Goh AC
    Contemporary techniques and outcomes of robotic cystectomy and intracorporeal urinary diversions.
    Curr Opin Urol. 2018;28:115-122.
    PubMed     Text format     Abstract available


    Curr Probl Cancer

  13. ZEKRI AN, Khaled HM, Mohammed MB, Diab FM, et al
    Microsatellite instability profiling in Egyptian bladder cancer patients: A pilot study.
    Curr Probl Cancer. 2019 Mar 26. pii: S0147-0272(18)30459.
    PubMed     Text format     Abstract available


    Eur Urol Oncol

  14. BEULENS AJW, van der Toorn PP, de Wildt MJ, Scheepens WA, et al
    High-precision Bladder Cancer Irradiation in the Elderly: Clinical Results for a Plan-of-the-day Integrated Boost Technique with Image Guidance Using Lipiodol Markers.
    Eur Urol Oncol. 2019;2:39-46.
    PubMed     Text format     Abstract available


    Front Oncol

  15. BODGI L, Bahmad HF, Araji T, Al Choboq J, et al
    Assessing Radiosensitivity of Bladder Cancer in vitro: A 2D vs. 3D Approach.
    Front Oncol. 2019;9:153.
    PubMed     Text format     Abstract available

  16. OH JJ, Byun SS, Jeong CW, Kwak C, et al
    Association Between Preoperative Hydronephrosis and Prognosis After Radical Cystectomy Among Patients With Bladder Cancer: A Systemic Review and Meta-Analysis.
    Front Oncol. 2019;9:158.
    PubMed     Text format     Abstract available


    Future Oncol

  17. FLANNERY K, Boyd M, Black-Shinn J, Robert N, et al
    Outcomes in patients with metastatic bladder cancer in the USA: a retrospective electronic medical record study.
    Future Oncol. 2019 Apr 3. doi: 10.2217/fon-2018-0654.
    PubMed     Text format     Abstract available


    Histopathology

  18. MCKENNEY JK
    Precursor lesions of the urinary bladder.
    Histopathology. 2019;74:68-76.
    PubMed     Text format     Abstract available

  19. PARK S, Reuter VE, Hansel DE
    Non-urothelial carcinomas of the bladder.
    Histopathology. 2019;74:97-111.
    PubMed     Text format     Abstract available


    In Vivo

  20. IZUMI K, Iwamoto H, Yaegashi H, Shigehara K, et al
    Gemcitabine Plus Cisplatin Split Versus Gemcitabine Plus Carboplatin for Advanced Urothelial Cancer With Cisplatin-unfit Renal Function.
    In Vivo. 2019;33:167-172.
    PubMed     Text format     Abstract available


    Indian J Cancer

  21. PRAKASH G, Pal M, Odaiyappan K, Shinde R, et al
    Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in India.
    Indian J Cancer. 2019;56:54-58.
    PubMed     Text format     Abstract available


    Int J Cancer

  22. SUN M, Zhao W, Chen Z, Li M, et al
    Circular RNA CEP128 Promotes Bladder Cancer Progression by Regulating Mir-145-5p/Myd88 Via Mapk Signaling Pathway.
    Int J Cancer. 2019 Apr 2. doi: 10.1002/ijc.32311.
    PubMed     Text format     Abstract available


    Int J Oncol

  23. LIN JF, Tsai TF, Lin YC, Chen HE, et al
    Benzyl isothiocyanate suppresses IGF1R, FGFR3 and mTOR expression by upregulation of miR-99a-5p in human bladder cancer cells.
    Int J Oncol. 2019 Mar 26. doi: 10.3892/ijo.2019.4763.
    PubMed     Text format     Abstract available

  24. SUGITA S, Yoshino H, Yonemori M, Miyamoto K, et al
    Tumorsuppressive microRNA223 targets WDR62 directly in bladder cancer.
    Int J Oncol. 2019 Mar 22. doi: 10.3892/ijo.2019.4762.
    PubMed     Text format     Abstract available


    Int Urol Nephrol

  25. MILOJEVIC B, Dzamic Z, Bojanic N, Durutovic O, et al
    Urothelial carcinoma of the upper urinary tract: preoperative pyuria is not correlated with bladder cancer recurrence and survival.
    Int Urol Nephrol. 2019 Apr 1. pii: 10.1007/s11255-019-02133.
    PubMed     Text format     Abstract available

  26. MAO W, Ma B, Huang X, Gu S, et al
    Which treatment is best for patients with AJCC stage IV bladder cancer?
    Int Urol Nephrol. 2019 Apr 4. pii: 10.1007/s11255-019-02105.
    PubMed     Text format     Abstract available


    J BUON

  27. KACHRILAS S, Dellis A, Papatsoris A, Avgeris S, et al
    PI3K/AKT pathway genetic alterations and dysregulation of expression in bladder cancer.
    J BUON. 2019;24:329-337.
    PubMed     Text format     Abstract available


    J Cell Mol Med

  28. GAO H, Yu G, Zhang X, Yu S, et al
    BZW2 gene knockdown induces cell growth inhibition, G1 arrest and apoptosis in muscle-invasive bladder cancers: A microarray pathway analysis.
    J Cell Mol Med. 2019 Apr 1. doi: 10.1111/jcmm.14266.
    PubMed     Text format     Abstract available


    J Cell Physiol

  29. LIANG T, Wang Y, Wang Y, Wang Y, et al
    Long noncoding RNA PEG10 facilitates bladder cancer cells proliferation, migration, and invasion via repressing microRNA-29b.
    J Cell Physiol. 2019 Apr 2. doi: 10.1002/jcp.28574.
    PubMed     Text format     Abstract available

  30. YAN X, Guo ZX, Liu XP, Feng YJ, et al
    Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis.
    J Cell Physiol. 2019 Mar 29. doi: 10.1002/jcp.28546.
    PubMed     Text format     Abstract available


    J Exp Clin Cancer Res

  31. MIAO L, Liu HY, Zhou C, He X, et al
    LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14.
    J Exp Clin Cancer Res. 2019;38:143.
    PubMed     Text format     Abstract available


    J Pathol

  32. YU CC, Li CF, Chen IH, Lai MT, et al
    YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo-/radio-resistance by suppressing caspase-mediated apoptosis.
    J Pathol. 2019 Apr 3. doi: 10.1002/path.5274.
    PubMed     Text format     Abstract available


    J Urol

  33. HAMILTON-REEVES JM, Stanley A, Bechtel MD, Yankee TM, et al
    Perioperative Immunonutrition Modulates Inflammatory Response after Radical Cystectomy: Results of a Pilot Randomized Controlled Clinical Trial.
    J Urol. 2018;200:292-301.
    PubMed     Text format     Abstract available


    Korean J Radiol

  34. KARAOSMANOGLU AD, Onur MR, Karcaaltincaba M, Akata D, et al
    Secondary Tumors of the Urinary System: An Imaging Conundrum.
    Korean J Radiol. 2018;19:742-751.
    PubMed     Text format     Abstract available


    Mod Pathol

  35. TRETIAKOVA M, Fulton R, Kocherginsky M, Long T, et al
    Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression.
    Mod Pathol. 2018;31:623-632.
    PubMed     Text format     Abstract available


    Mol Cancer Ther

  36. WANG F, Zhang H, Ma AH, Yu W, et al
    COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin.
    Mol Cancer Ther. 2018;17:474-483.
    PubMed     Text format     Abstract available


    Mol Immunol

  37. MU XY, Wang RJ, Yao ZX, Zheng Z, et al
    RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment.
    Mol Immunol. 2019;109:140-148.
    PubMed     Text format     Abstract available


    Mol Ther

  38. XIE Q, Chen C, Li H, Xu J, et al
    miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription.
    Mol Ther. 2019 Mar 15. pii: S1525-0016(19)30092.
    PubMed     Text format     Abstract available


    Oncologist

  39. NICOLAZZO C, Busetto GM, Gradilone A, Sperduti I, et al
    Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial.
    Oncologist. 2019 Apr 3. pii: theoncologist.2018-0784.
    PubMed     Text format     Abstract available


    Scand J Urol

  40. NILBERT M, Blackberg M, Ceberg J, Hagberg O, et al
    Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria.
    Scand J Urol. 2018;52:237-243.
    PubMed     Text format     Abstract available


    Toxicol Appl Pharmacol

  41. ZHU Q, Sheng Y, Li W, Wang J, et al
    Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits bladder cancer cell growth via the mitochondrial apoptosis and JNK pathways.
    Toxicol Appl Pharmacol. 2019 Apr 1. pii: S0041-008X(19)30117.
    PubMed     Text format     Abstract available


    World J Urol

  42. BOERI L, Montanari E, Karnes RJ
    Reply letter to: Peyton CC, Tang D, Reich RR, et al. Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer. JAMA Oncol. 2018 Nov 1;4(11):1535-1542.
    World J Urol. 2019 Apr 3. pii: 10.1007/s00345-019-02751.
    PubMed     Text format    


    Zhonghua Wai Ke Za Zhi

  43. HAO YC, Xiao CL, Liu K, Liu YQ, et al
    [Application of narrow-band imaging flexible ureteroscopy in the diagnosis, treatment and follow-up of upper tract urothelial carcinomas].
    Zhonghua Wai Ke Za Zhi. 2018;56:222-226.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: